DiaMedica Therapeutics Inc.
DMAC | NASDAQ
$7.45
+$0.19 (+2.62%)
Sep 22, 2026, 10:53 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -38.86M | -36.74M | -34.4M | -33.6M | -31.45M | -29.08M | -26.68M | -24.11M | -22.38M | -21.49M | -21.27M | -19.39M | -17.36M | -15.99M | -14M | -13.27M | -13.56M | -13.56M | -13.65M | -14.67M | -14.57M | -13.91M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 353K | 353K | 353K | 388K | 35K | 35K | 35K | 4K | 4K | 4K | 4K |
Pretax Income | -37.51M | -35.07M | -32.74M | -31.9M | -29.55M | -26.97M | -24.41M | -21.66M | -19.86M | -19.22M | -19.34M | -17.94M | -16.53M | -15.41M | -13.65M | -13.14M | -13.53M | -13.45M | -13.56M | -14.52M | -14.27M | -13.46M |
Net Income | -37.54M | -35.1M | -32.77M | -31.93M | -29.58M | -27M | -24.44M | -21.71M | -19.9M | -19.26M | -19.38M | -17.97M | -16.56M | -15.44M | -13.68M | -13.17M | -13.56M | -13.48M | -13.59M | -14.55M | -14.29M | -13.49M |
Selling & General & Admin | 9.95M | 9.79M | 9.78M | 9.22M | 8.52M | 8.05M | 7.62M | 7.85M | 7.83M | 8.32M | 8.16M | 7.69M | 7.29M | 6.5M | 6.16M | 5.83M | 5.43M | 5.23M | 4.88M | 4.65M | 4.73M | 4.63M |
Research & Development | 29.28M | 26.95M | 24.61M | 24.39M | 22.93M | 21.04M | 19.06M | 16.26M | 14.55M | 13.17M | 13.11M | 11.7M | 10.07M | 9.48M | 7.84M | 7.44M | 8.13M | 8.33M | 8.77M | 10.01M | 9.84M | 9.28M |
Other Expenses | -366K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 38.86M | 36.74M | 34.4M | 33.6M | 31.45M | 29.08M | 26.68M | 24.11M | 22.38M | 21.49M | 21.27M | 19.39M | 17.36M | 15.99M | 14M | 13.27M | 13.56M | 13.56M | 13.65M | 14.67M | 14.57M | 13.91M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 159K | 159K | 159K | 159K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.86M | 36.74M | 34.4M | 33.6M | 31.45M | 29.08M | 26.68M | 24.11M | 22.38M | 21.49M | 21.27M | 19.39M | 17.36M | 15.99M | 14M | 13.27M | 13.56M | 13.56M | 13.65M | 14.67M | 14.57M | 13.91M |
Income Tax Expense | 16K | 15K | 28K | 27K | 28K | 29K | 30K | 43K | 43K | 43K | 43K | 28K | 28K | 28K | 28K | 28K | 28K | 28K | 28K | 28K | 23K | 25K |
Shares Outstanding (Basic) | 53.89M | 53.79M | 46.98M | 49.63M | 42.96M | 42.84M | 42.82M | 42.75M | 38.07M | 37.96M | 37.96M | 37.95M | 27.31M | 26.45M | 26.44M | 26.44M | 26.44M | 26.44M | 19.04M | 19.04M | 18.79M | 18.77M |
Shares Outstanding (Diluted) | 53.89M | 53.79M | 46.98M | 49.63M | 42.96M | 42.84M | 42.82M | 42.75M | 38.07M | 37.96M | 37.96M | 37.95M | 27.31M | 26.45M | 26.44M | 26.44M | 26.44M | 26.44M | 19.04M | 19.04M | 18.79M | 18.77M |
EPS (Basic) | -0.72 | -0.71 | -0.70 | -0.71 | -0.69 | -0.64 | -0.60 | -0.56 | -0.53 | -0.56 | -0.62 | -0.62 | -0.62 | -0.59 | -0.52 | -0.55 | -0.61 | -0.65 | -0.71 | -0.79 | -0.80 | -0.80 |
EPS (Diluted) | -0.72 | -0.71 | -0.70 | -0.71 | -0.69 | -0.64 | -0.60 | -0.56 | -0.53 | -0.56 | -0.62 | -0.62 | -0.62 | -0.59 | -0.52 | -0.55 | -0.61 | -0.65 | -0.71 | -0.79 | -0.80 | -0.80 |
EBITDA | -37.09M | -35.03M | -32.7M | -31.86M | -29.52M | -26.93M | -24.38M | -21.63M | -19.83M | -19.19M | -19.31M | -17.76M | -16.35M | -15.23M | -13.46M | -13.12M | -13.51M | -13.43M | -13.54M | -14.57M | -14.43M | -13.8M |
EBIT | -37.51M | -35.07M | -32.74M | -31.9M | -29.55M | -26.97M | -24.41M | -21.66M | -19.86M | -19.22M | -19.34M | -17.78M | -16.37M | -15.25M | -13.49M | -13.14M | -13.53M | -13.45M | -13.57M | -14.6M | -14.45M | -13.82M |
Depreciation & Amortization | 422K | 43K | 43K | 43K | 35K | 42K | 39K | 36K | 34K | 31K | 30K | 28K | 27K | 26K | 25K | 25K | 24K | 24K | 24K | 23K | 22K | 21K |
Add to Watchlist
Select watchlists to add or remove DMAC